Article
Intratumoral Heterogeneity of Ki67 Proliferation Index Outperforms Conventional Prognostic Factors in Hormone Receptor-Positive Breast Cancer
2023-08-31
Abstract excerpt
<h4>Background: </h4> Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used in breast cancer (BC) pathology to assess tumor properties and predict patient outcomes and therapy responses. Visual scoring of the IHC biomarkers by pathologists, apart from reproducibility issues, does not sufficiently account for the intratumoral heterogeneity (ITH), often a subvisual feature within the tumor tissue. It has bee...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2da312d3-72a9-5279-9eaa-8b622dbd9e1b
- DOI
- 10.21203/rs.3.rs-3302114/v1
